Teva

Harmful Patent Strategies

EU Commission imposes heavy fine of €462.6 million on Teva for abuse of dominant market position.

Teva Intends to Divest API Business

Israeli generics manufacturer Teva Pharmaceuticals intends to divest its active pharmaceutical ingredient (API) business, Teva API (TAPI). A standalone business unit of Teva, TAPI supplies APIs to over 1,000 customers worldwide and has approximately 4,300 employees worldwide.

Sanofi Enters into Partnerships with Janssen and Teva

Sanofi has entered into an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, to develop and commercialize the vaccine candidate for extraintestinal pathogenic E. coli (9-valent) developed by Janssen, a potential first-in-class product currently in Phase 3.

Flamma Invests $200 Million to Expand CDMO Capabilities

Italian CDMO Flamma Group intends to invest $200 million over the next three years to expand its capabilities to meet growing market demand.

Generic Price-fixing Probe may See Progress

Reckitt Settles Opioid Case, Teva Deal Questioned

Ohio Settles with Four US Opioid Players

US Opioid Settlement Talks in High Gear

Continuous Processing

Opioid Makers Angling to Settle out of Court

J&J Told to Pay $572 Million in Opioid Case

Teva Faces Israeli Back-tax Claim

DCAT Announces New Board of Directors

FDA Approves Teva’s Generic EpiPen

Warren Buffett Invests in Teva

Loss-making Teva Progresses Turnaround

Teva Takes Back a few Job Cuts

Teva Rejects Pleas to Save Israeli Jobs

Teva Confirms Massive Cost Cuts, Job Losses

Teva Realigns, may Slash 25% of Workforce

Teva Sheds Assets Worth $2.48 Billion

Kare Schultz Named CEO of Teva

Teva Reduces Israeli Job cut Numbers

Teva Cuts Jobs, Closes Plants as Woes Deepen

EU Accuses Teva and Cephalon of Antitrust Breach

UK Supreme Court Upholds Lily Alimta Patent

Teva Facing Bribery Charges in Israel

Teva CEO Erez Vigodman Steps Down

Mylan Faces FTC Investigation on EpiPen

Teva Pays $225 Million to Settle Cipro Suit

Teva Shareholders Criticize Generics CEO Switch

Teva and IBM Expand e-Health Alliance

Teva to Sell UK and Irish Assets to Accord Healthcare

Teva Launches Generic Epzicom Tablets in US

Teva to Buy Anda from Allergan